NFIB and glioblastoma: However, we saw a decrease in GFAP expression in the proneural and neural GBM cell lines, suggesting a lack of differentiation and supporting our previous observations in xenograft models where NFIB afforded no survival benefit and was even oncogenic in the neural subtype.